Lack of cholesterol-lowering effect of graded doses of cholestyramine in children with Alagille syndrome: A pilot study

Journal of Pediatric Gastroenterology and Nutrition

Volumn 36, Issue 1, 2003, Pages 50-53

  Larrosa Haro, Alfredo ^a,b,c,d   Sáenz Rivera, Cecilia ^a,c   González Ortiz, Manuel ^b,c   Coello Ramírez, Pedro ^a,c   Vázquez Camacho, Gonzalo ^c  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d NONE   (Mexico)

Author keywords

Alagille syndrome; Cholestyramine; Hypercholesterolemia

Indexed keywords

BILE ACID; CHOLESTEROL; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ALAGILLE SYNDROME; ARTICLE; ATHEROGENESIS; CHILD; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 20; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOMINANT INHERITANCE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; LIVER FUNCTION TEST; PRIORITY JOURNAL; BLOOD; DOSE RESPONSE; FEMALE; MALE; PILOT STUDY; PRESCHOOL CHILD;

ALAGILLE SYNDROME; ANTICHOLESTEREMIC AGENTS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTYRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PILOT PROJECTS; TRIGLYCERIDES;

EID: 19044362111     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200301000-00011     Document Type: Article

References (21)

1. Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alasille syndrome. Nature Genet 1997;16:235-12.
2. Alagille D, Estrada A, Hadchuel M, Gautier M, Odièvre M, Dommergues JP. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): Review of 80 cases. J Pediatr 1987;110:195-200.
3. Gottrand F, Clavey V, Fruchart JC, Farriaux JP. Lipoprotein pattern and plasma lecithin cholesterol acyl transferase activity in children with Alagille syndrome. Atherosclerosis 1995;115:233-41.
4. Bousvaros A. Colestasis neonatal. Semin Int Gastroenterol Nutr Pediatr 1999;8:1-15.
5. Soros P, Bottcher J, Maschek H, Selberg O, Muller MJ. Lipoprotein-X in patients with cirrhosis: Its relationship to cholestasis and hypercholesterolemia. Hepatology 1998;28:1199-205.
6. Sokol RJ. Medical management of neonatal cholestasis. In: Balistreri W, Stocker JT, eds. Pediatric hepatology. New York: Hemisphere Publishing Corporation, 1990:41-76.
7. Quiros-Tejeira RE, Ament ME, et al. Variable morbidity in Alagille syndrome: A review of 43 cases. J Pediatr Gastroenterol Nutr 1999;29:431-7.
8. Pombo F, Isla C, Gayol A, Bargiela A. Aortic calcification and renal cysts demonstrated by CT in a teenager with Alagille syndrome. Pediatr Radiol 1995;25:314-5.
9. Gonzalez ER. The pharmacoeconomic benefits of cholesterol reduction. Am J Manag Care 1998;4:223-30.
10. Lottsfeldt FL, Krivit W, Aust JB, Carey JB. Cholestyramine therapy in intrahepatic biliary atresia. N Engl J Med 1963;269:186.
11. Sharp HL, Carey JB, White JG, Krivit W. Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts. J Pediatr 1967;71:723-36.
12. Javitt NB, Morrissey KP, Siegel E, et al. Cholestatic syndromes in infancy: Diagnostic value of serum bile acid pattern and cholestyramine administration. Pediatr Res 1973;7:119-25.
13. Levy JS, Gelb AM, Stenger RJ, Javitt NB. Prolonged neonatal cholestasis: Bile acid pattern and response to cholestyramine. Mt Sinai J Med 1979;46:169.
14. Shepherd J, Packard CJ, Bicker S, Lawrie TDV, Morgan HG. Cholestyramine promotes receptor mediated low density-lipoprotein catabolism. N Engl J Med 1980;302:1219.
15. Martínez R, Espinoza M, González A, Cantú JM. Escaséz congénita sindromática de los conductos biliares intrahepáticos: Síndrome de Alagille. Informe de dos casos tratados con colestiramina. Rev Med IMSS 1986;24:265-72.
16. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial. J Pediatr 1997;130:266-73.
17. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:1015-23.
18. Davit-Spraul A, Pourci ML, Atger V, et al. Abnormal lipoprotein pattern in patients with Alagille syndrome depends on icterus severity. Gastroenterology 1996;111:1023-32.
19. Dupont J, Raulin J, Gautier M, et al. Cholesterol and prostaglandin synthesis by cultured human skin fibroblasts in the Alagille syndrome involving paucity of interlobular bile ducts. J Inherit Metab Dis 1989;12:436-44.
20. American Academy of Pediatrics, Comitee on Nutrition. Cholesterol in childhood. Pediatrics 1998;101:141-7.
21. Simons LA. Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study). Aust N Z J Med 1998;28:327-33.